Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi‐site trial
Addiction2013Vol. 109(1), pp. 79–87
Citations Over TimeTop 1% of 2013 papers
Yih‐Ing Hser, Andrew J. Saxon, David Huang, Al Hasson, Christie Thomas, Maureen Hillhouse, Petra Jacobs, Cheryl Teruya, Paul McLaughlin, Katharina Wiest, Allan Cohen, Walter Ling
Abstract
Provision of methadone appears to be associated with better retention in treatment for opioid dependence than buprenorphine, as does use of provision of higher doses of both medications. Provision of buprenorphine is associated with lower continued use of illicit opioids.
Related Papers
- → Attitudes Toward Buprenorphine and Methadone Among Opioid‐Dependent Individuals(2008)127 cited
- → Transition From Methadone to Buprenorphine Using a Short-acting Agonist Bridge in the Inpatient Setting: A Case Study(2020)16 cited
- → Fatal Poisoning in Methadone and Buprenorphine Treated Patients - Are there Differences?(2006)26 cited
- → Treatment of Chronic Methadone Dependence with Buprenorphine(2016)2 cited
- → Successful Rapid Transition from Methadone to Buprenorphine without Bridging Methods: A Case Report(2024)